Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
17 Oct 2016 EMA Recommends Granting a Conditional Marketing Authorisation for Venetoclax Haematologic malignancies - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016 Press Release: Longer Disease-free Survival in Phase III Trial of Sunitinib as Adjuvant Treatment for Kidney Cancer Genitourinary cancers
09 Oct 2016 ESMO 2016 Press Release: Nivolumab Maintains Function and Reduces Symptoms in Relapsed Metastatic Head and Neck Cancer Head and neck cancers
08 Oct 2016 ESMO 2016 Press Release: Niraparib Significantly Improves Outcome of Ovarian Cancer Patients in Landmark Trial Gynaecologic malignancies
08 Oct 2016 ESMO 2016 Press Release: Ribociclib Improves Progression-free Survival in Advanced Breast Cancer Breast cancer - Anticancer agents & Biologic therapy
08 Oct 2016 ESMO 2016 Press Release: Ipilimumab as Adjuvant Therapy Improves Overall Survival in High Risk Stage III Melanoma Melanoma
10 Oct 2016 ESMO 2016: The NETwork! Translational Programme Facilitates Genomic Analysis of Neuroendocrine Tumours Translational research - Endocrine cancers
10 Oct 2016 ESMO 2016: Metformin Significantly Lowers the Risk of Cancer Progression in Patients with Diabetes and Advanced pNETs Endocrine cancers - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: Clinical Benefit Demonstrated with Everolimus and Pasireotide LAR Alone or in Combination in the First Randomised, Prospective Study Entirely Dedicated to Advanced Lung and Thymic Carcinoids Endocrine cancers - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: Meta-Analysis Confirms Superiority of Concomitant Over Induction Chemotherapy in Non-Metastatic HNSCC Head and neck cancers
10 Oct 2016 ESMO 2016: PD-L1 Expression as a Biomarker for Checkpoint Inhibitors Response in Patients with Advanced Melanoma Melanoma - Cancer Immunology and Immunotherapy
10 Oct 2016 ESMO 2016: Baseline Genetic Features Elucidated in Responding and Non-Responding Patients with BRAFV600-Mutated Melanoma Translational research - Melanoma
10 Oct 2016 ESMO 2016: ERBB2 Gene Alterations May Be Prognostic of Poorer Outcome in Stage III Colon Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016: Results of the First Cohort of Patients Screened Within the New EORTC Molecular Platform for Patients With Colorectal Cancer Translational research - Gastrointestinal cancers
10 Oct 2016 ESMO 2016 Press Release: Single-Arm Trials Improve Early Access to Rare Cancer Drugs Translational research